Multiple Sclerosis Clinical Trial

Clinical Trial Finder Multiple Sclerosis Trials

Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS

See Locations Near You

Summary

The purpose of this study is to learn about the pharmacokinetics and pharmacodynamics of RPC1063 in RMS.

View Full Description

Full Description

The purpose of this study is to characterize the full pharmacokinetic and pharmacodynamics profiles of RPC1063 in patients with relapsing multiple sclerosis (RMS) following multiple-dose administration of the two different dosing regimens that are being evaluated in the Phase 3 RMS studies.

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

MS, as diagnosed by the revised 2010 McDonald criteria
Exhibits a relapsing clinical course consistent with RMS and history of brain MRI lesions consistent with MS
Expanded disability status scale (EDSS) score between 0 and 6.0

Key Exclusion Criteria:

Primary progressive MS
Clinically relevant cardiovascular conditions or other relevant diseases that could impact the implementation or interpretation of the trial, or put the patient at risk

Study is for people with:

Multiple Sclerosis

Phase:

Phase 1

Estimated Enrollment:

22

Study ID:

NCT02797015

Recruitment Status:

Completed

Sponsor:

Celgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Breastlink Medical Group, Inc.
Long Beach California, 90806, United States
Multiple Sclerosis Center at UCSF
San Francisco California, 94158, United States
Raleigh Neurology Associates PA
Raleigh North Carolina, 27607, United States
Neurology and Neuroscience Associates Inc.
Akron Ohio, 44320, United States
Hope Neurology MS Center
Knoxville Tennessee, 37922, United States
Central Texas Neurology Consultants PA
Round Rock Texas, 78681, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 1

Estimated Enrollment:

22

Study ID:

NCT02797015

Recruitment Status:

Completed

Sponsor:


Celgene

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider